Therefore, the aims of this study are to investigate the association between plasma copeptin and the presence and severity of NAFLD/NASH and to analyze clinical correlates of increased copeptin levels. The gene discussed is AVP; the disease is metabolic dysfunction-associated steatotic liver disease.